RASSF8 and colorectal cancer: On the contrary, MEK/ERK inhibitor Ras Association Domain Family Member 2 (RASSF2) is targeted by miR-200a, miR-200c, miR-141 in colorectal cancer, and Ras Association Domain-Containing Protein 8 (RASSF8) by miR-429 in non-small lung carcinoma which results in increased proliferation (56, 308).